Douglas A Roeder Net Worth & Insider Trades

Douglas A Roeder - Director, Tandem Diabetes Care Inc

As of May 19, 2022

What is Douglas A Roeder's Net Worth?

The current estimated net worth of Tandem Diabetes Care Inc's Director, Douglas A Roeder, is estimated to be about $55.74M . Douglas A Roeder owns about 12,651 units of Tandem Diabetes Care Inc common stock. In the last 9 years at Tandem Diabetes Care Inc, Douglas A Roeder has sold an estimated value of $4.1M worth.

What is Douglas A Roeder's Past Insider Trading?

Douglas A Roeder's largest purchase order was 1,000,000 units , worth over $2M on February 13, 2018. Douglas A Roeder's largest sale order was 35,688 units , worth over $2.5M on June 17, 2019. In total, Douglas A Roeder has made about 19 transactions over 9 years of their time at Tandem Diabetes Care Inc. Douglas A Roeder usually trades in November, with the busiest year in 2019 and 2021. The most recent transaction was a sale order of 9,471 units , worth over $663.08K on August 6, 2019.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Douglas A Roeder

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Douglas A Roeder's' Mailing Address?

  • Mailing address is 160 Bovet Rd, Suite 408 C/o Delphi Ventures San Mateo CA 94402 CA

Tandem Diabetes Care Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John F. Sheridan 2020 $600,000 $60,385 $422,692 $1,619,976 $422,692 $7,715 $3,790,739
John F. Sheridan 2019 $500,000 - $738,225 $9,319,134 $738,225 $3,578 $10,560,937
John F. Sheridan 2018 $386,250 - $350,863 $1,197,532 $350,863 $2,772 $1,937,417
Leigh A. Vosseller 2020 $412,000 $25,532 $178,726 $803,352 $178,726 $1,910 $1,957,059
Leigh A. Vosseller 2019 $400,000 - $368,110 $4,621,634 $368,110 $1,708 $5,391,452
Leigh A. Vosseller 2018 $386,250 - $331,568 $1,197,532 $331,568 $630 $1,915,980
David B. Berger 2020 $412,000 $25,532 $178,726 $803,352 $178,726 $1,397 $1,956,546
David B. Berger 2019 $400,000 - $368,110 $4,621,634 $368,110 $1,144 $5,390,888
David B. Berger 2018 $386,250 - $350,863 $1,197,532 $350,863 $630 $1,935,275
Brian B. Hansen 2020 $412,000 $25,532 $178,726 $803,352 $178,726 $2,396 $1,957,545
Brian B. Hansen 2019 $400,000 - $368,110 $4,621,634 $368,110 $10,153 $5,399,897
Brian B. Hansen 2018 $386,250 - $350,863 $1,197,532 $350,863 $966 $1,935,611
Susan M. Morrison 2020 $412,000 $25,532 $178,726 $803,352 $178,726 $608 $1,955,757
Susan M. Morrison 2019 $400,000 - $368,110 $4,621,634 $368,110 $497 $5,390,241
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1438133/000143813321000025/a2021proxy-tndmdef14a.htm

What are Tandem Diabetes Care Inc's Past Insider Trades?

Tandem Diabetes Care Inc's most recent insider trade came on November 29, 2023 by Dick Allen who bought 5,000 units worth $94.78K . In the last 10 years, insiders at Tandem Diabetes Care Inc have sold an estimated value of $299.44M and bought an estimated value of $45.88M worth of shares. Insider trading is most common in November, with the busiest year in 2022. The most active traders at the company are David B Berger, EVP & Chief Operating Officer,  John F Sheridan, PRESIDENT & CEO,  and Brian B Hansen, EVP & CHIEF COMMERCIAL OFFICER .

TANDEM DIABETES CARE INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...